1. High rate of persistent symptoms up to 4 months after community and hospital-managed SARS-CoV-2 infection
- Author
-
Darley, David R, Dore, Gregory J, Cysique, Lucette, Wilhelm, Kay A, Andresen, David, Tonga, Katrina, Stone, Emily, Byrne, Anthony, Plit, Marshall, Masters, Jeffrey, Tang, Helen, Brew, Bruce, Cunningham, Philip, Kelleher, Anthony, Matthews, Gail, Mistry, Sandeep G, Walker, Wallace, Earnshaw, James, Cervin, Anders, Gidding, Heather F, Machalek, Dorothy A, Hendry, Alexandra J, Quinn, Helen E, Vette, Kaitlyn, Beard, Frank H, Shilling, Hannah, Hirani, Rena, Gosbell, Ian B, Irving, David O, Hueston, Linda, Downes, Marnie, Carlin, John B, O'Sullivan, Matthew NV, Dwyer, Dominic E, Kaldor, John M, Macartney, Kristine, d'Emden, Michael C, Ungerer, Jacobus PJ, de Jersey, Susan J, Johnston, Kate, Tyson, Chloe, Danny, Indra, Meyer, Lois, Heriot, George S, Jamrozik, Euzebiusz, Way, Teagan L, Tarrant, Seth M, Balogh, Zsolt L, Stanaway, Fiona, Irwig, Les, Teixeira-Pinto, Armando, Bell, Katy J.L., Horvath, Andrea R, Loy, Clement, Burrell, Aiden JC, Pellegrini, Breanna, Salimi, Farhad, Begum, Husna, Broadley, Tessa, Campbell, Lewis T, Cheng, Allen C, Cheung, Winston, Cooper, D James, Earnest, Arul, Erickson, Simon J, French, Craig J, Litton, Edward, Murthy, Srinivas, McAllister, Richard, Nichol, Alistair, Palermo, Annamaria, Plummer, Mark, Ramanan, Mahesh, Reddi, Benjamin, Reynolds, Claire, Trapani, Tony, Webb, Steven AR, Udy, Andrew, Hao Tran, Tu, Sasikumar, Suraj Narayanan, Hennessy, Annamarie, O’Loughlin, Aiden, Morgan, Lucy, Blakely, Tony, Thompson, Jason, Carvalho, Natalie, Bablani, Laxman, Wilson, Nick, Stevenson, Mark, Scott, Nick, Palmer, Anna, Delport, Dominic, Abeysuriya, Romesh, Stuart, Robyn, Kerr, Cliff C, Mistry, Dina, Klein, Daniel, Sacks-Davis, Rachel, Heath, Katie, and Hainsworth, Samuel
- Subjects
body regions ,SARS-CoV-2 ,viruses ,fungi ,virus diseases ,skin and connective tissue diseases ,1117 Public Health and Health Services - Abstract
Recovery after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection remains uncertain. A considerable proportion of patients experience persistent symptoms after SARS-CoV-2 infection which impacts health-related quality of life and physical function.
- Published
- 2020